Jobs

Discover opportunities across our network
Camford Capital
Camford Capital
22
companies
198
Jobs
CG Oncology
CG Oncology
cgoncology.com

Locations

Irvine, CA, USA

Bio

CG Oncology is a clinical-stage biotechnology company focused on developing the next evolution of oncolytic immunotherapy for patients with advanced cancer. Our lead candidate, CG0070, is a selective oncolytic immunotherapy in multiple clinical programs, including ongoing trials with CG0070 as a monotherapy in a global Phase 3 study (BOND3) for the treatment of BCG-unresponsive, Non-Muscle Invasive Bladder Cancer (NMIBC), and also in combination with KEYTRUDA® (pembrolizumab) in a Phase 2 study (CORE1) in the same indication. Additional indications in muscle-invasive bladder cancer (MIBC) and other solid tumors are being pursued with CG0070 in combination with immune checkpoint modulators.

Something looks off?
Open jobs at CG Oncology